Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The purinergic P1 receptor, also known as the adenosine receptor, is a class of G protein-coupled receptors (GPCRs) that are activated by adenosine. These receptors play key roles in regulating physiological processes in various tissues throughout the body. There are four recognized subtypes: A1, A2A, A2B, and A3. Each subtype exhibits distinct tissue distribution and functional roles. They regulate diverse functions like neurotransmitter release, myocardial oxygen consumption, inflammatory responses, and immune system modulation. Drugs targeting these receptors have therapeutic applications, such as cardiac arrhythmia treatment, myocardial perfusion imaging, and the stimulant effects from dietary methylxanthines.
A1 and A3: Coupled to Gi/Go proteins → inhibit adenylate cyclase → decrease cAMP levels. A2A and A2B: Coupled to Gs proteins → stimulate adenylate cyclase → increase cAMP levels
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Purinergic P1 receptor.